Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors by Christopher Morehouse, Rakesh Kumar, Antoine Hollebecque, Aurélien Marabelle, Zachary A Cooper, Joshua Brody, Farzana Walcott, Charles Ferte, Shilpa Gupta, David S Hong, Lillian Siu, Antonio Jimeno, Pamela Munster, Juneko Grilley-Olson, Alain H Rook, Rebecca K S Wong, James W Welsh, Yuling Wu, Oday Hamid

Get full text

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers by Aurélien Marabelle, Aung Naing, Funda Meric-Bernstam, Xingfeng Bao, Andrea Varga, David S Hong, Aparna Parikh, Geoffrey I Shapiro, Özlem Ataman, Larisa Reyderman, Terri A Binder, Min Ren, Mingjie Liu, Satish Dayal, Amy Y Siu, Pallavi Sachdev, Lucy Xu, Vijay Bhagawati-Prasad, Ilian Tchakov, Chean Eng Ooi

Get full text

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma by Adi Diab, James Welsh, Isabella Glitza, Hari Menon, Dawei Chen, Rishab Ramapriyan, Renata Ferrarotto, Alexandra P Cadena, Maria Angelica Cortez, David S Hong, Hampartsoum B Barsoumian, Ahmed I Younes, Quynh-Nhu Nguyen, Nathan I Comeaux, Mauricio S Caetano, Taylor R Cushman, Jonathan E Schoenhals, Timothy P Reilly, Fatemeh Masrorpour, Ailin Li, Stephen G Chun

Get full text

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory by Vivek Subbiah, Jing Gong, Siqing Fu, Aung Naing, Shubham Pant, Filip Janku, Mehmet Altan, Kenneth Hess, Ajay Sheshadri, Lilibeth Castillo, Bettzy Stephen, David S Hong, Sarina A Piha-Paul, Tito Mendoza, Goldy George, Enedelia Rodriguez, Christine Peterson, Jordi Rodon Ahnert, Ecaterina Dumbrava, Timonthy A Yap, Apostolia M Tsimberidou, Daniel D Karp, Abdulrazzak Zarifa, Lacey M McQuinn, Charles Cleeland

Get full text

Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch re... by Heather Lin, Vivek Subbiah, Siqing Fu, Aung Naing, Courtney Nicholas, Shubham Pant, Chad Tang, Michael A Curran, David S Hong, Ying Yuan, Sarina A Piha-Paul, Jordi Rodon Ahnert, Timonthy A Yap, Apostolia M Tsimberidou, Daniel D Karp, Anupallavi Srinivasamani, Coline Couillault, Genevieve P Hartley, James Dai, Ecaterina E Ileana Dumbrava, Paola Guerrero, Sarah Dhebat, Theresa Proia

Get full text

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies by Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud

Get full text

Phase 2 study of pembrolizumab in patients with advanced rare cancers by Vivek Subbiah, Linghua Wang, Sara Ahmed, Michael Frumovitz, Jing Gong, Chantale Bernatchez, Siqing Fu, Aung Naing, Funda Meric-Bernstam, Shubham Pant, Nizar Tannir, Renata Ferrarotto, Joud Hajjar, Shi-Ming Tu, Mingxuan Xu, Anas Alshawa, Bettzy Stephen, Matthew Campbell, David S Hong, Sarina A Piha-Paul, Jordi Rodon Ahnert, Apostolia M Tsimberidou, Daniel D Karp, Timothy A Yap, Rivka R Colen, Vinod Ravi, Camilo Jimenez, Kanwal P Raghav, Gauri R Varadhachary, Ecaterina E Ileana Dumbrava, Sarjeel H Sabir, Saria Khan, Jeane M Painter, Abulrahman Abonofal, Richard M Simon

Get full text